ADAM, a biotechnical initiative based at BioCT Innovation Commons in Groton, has set a new milestone in in medical technology by launching the 3D bioprinting of organic bone structures.
The core of ADAM’s approach is the combination of new materials for 3D printing. One is a modified biopolymer based on polycaprolactone with the addition of hydroxyapatite, which has high strength and good bioresorbability. Another is a ceramic bioglass based on hydroxyapatite and borosilicate glass, which is able to react with bone tissue to effectively connect with the implant and stimulate osteogenesis.